MAGL Targeted PROTAC Degrader Simultaneously Enhances P53 for Synergistic Treatment of Glioblastoma Stem Cell

ABSTRACT: This study focuses on the protein degradation effects of the MAGL inhibitor JZL184 and the newly synthesized MAGL-PROTAC on MAGL.

ORGANISM(S): Homo Sapiens

SUBMITTER: JinLong Yin  

PROVIDER: PXD058506 | iProX | Mon Dec 02 00:00:00 GMT 2024

REPOSITORIES: iProX